Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJAV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,213
Award facts
- Contract value 100% obligated
- $14,213.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,213.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of pharmaceutical products and medical consumables to the Department of Defense, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy established to support recurring medical supply needs of military healthcare facilities worldwide. The underlying IDC, designated as contract SPE2DR and awarded on November 13, 2025, features a 30-month base period with three 30-month option periods extending through December 31, 2036. Through this vehicle, DMS Pharmaceutical Group has demonstrated substantial performance across numerous delivery orders, positioning itself as one of multiple regional prime vendor contractors supporting the Department of Defense's global healthcare operations with diverse and specialized pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DU26FEJAV?
SPE2DU26FEJAV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DU26FEJAV worth?
The government has obligated $14,213 on SPE2DU26FEJAV.
Is contract SPE2DU26FEJAV an order under another contract?
Yes. SPE2DU26FEJAV is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJAV competed?
The extent of competition for SPE2DU26FEJAV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award